British & American Investment Trust PLC
Interim Management Statement - 3 months to 30 September 2014
To the members of British & American Investment Trust PLC
This interim management statement has been produced solely to provide
additional information to shareholders as a body to meet the relevant
requirements of the UK Listing Authority's Disclosure and Transparency Rules.
It should not be relied upon by any other party or for any other purpose.
This interim management statement relates to the period from 1 July 2014 to 30
September 2014, and contains information that covers this period, and up to the
date of publication of this interim management statement, unless otherwise
specified.
Investment objective
To invest predominantly in investment trusts and other leading UK quoted
companies to achieve a balance of income and growth.
Benchmark
FTSE All-Share Index and FTSE 100 Index.
Material developments
On 28 August 2014 the company reported its Half Year results to 30 June 2014.
An interim ordinary dividend of 2.7p is to be paid on 6 November 2014 to
shareholders on the register at 9 October 2014. A dividend of 1.75p per share
is to be paid to preference shareholders on 6 November 2014.
Twenty largest equity holdings at 30 September 2014 (group basis)
%
Geron Corporation 16.52
Dunedin Income Growth 10.12
Rit Capital Partners 8.00
British Assets Trust 7.73
Prudential 7.64
St. James's Place Global Equity 7.26
Biotime Inc NPV 4.80
Biotime Series A Convertible Preferred Stock 4.74
Scottish & American Investment Company 3.68
Invesco Income Growth Trust 3.20
Alliance Trust 3.04
F&C Asset Management - 6.75% FRN Sub. Bonds 2026 2.35
Earthport 2.21
Royal & Sun Alliance Insurance Group - 7.375% Cum. irred. preference
shares £1 2.02
Shires Income 1.87
Merchants Trust 1.86
Rothschilds Continuation Finance - 9% Perp. Sub. Gtd. Loan Notes 1.80
Asterias Biotherapeutics Series A Common Stock 1.64
Barclays Bank - 9% PIB Capital Bonds 0.98
Jupiter Income Trust 0.86
Total 92.32
Sector allocation as at 30 September 2014 (group basis)
%
Investment Trusts (equities) 41.32
Biomedical 16.52
Biotechnology 9.72
Unit Trusts 8.12
Life Assurance 7.64
Software and computer services 2.55
Pharmaceuticals 1.78
Other Financial 0.40
Support services 0.34
Telecommunications 0.29
Leisure and hotels 0.15
Overseas 0.09
Financial services 0.07
Fixed Interest Stocks excluding Preference 4.15
Preference 2.59
Derivatives - traded options 2.17
Permanent Interest Bearing 1.21
Property Units - EZT 0.89
Total 100.00
Key facts
Performance
As at As at As at As at As at
30 30 30 30 30
September September September September September
2014 2014 2013 2011 2009
Year to 1 year 3 years 5 years
date
Total assets (000) 24,576
Short term borrowings (000) 2,523
Actual gearing 10.38 %
NAV (p) 70.2
FTSE All-Share 3,533.93
Share price (p) 84.0 -21.1% -1.8% 21.7% -6.7%
Premium/(discount) 19.7% 4.1% -5.3% -6.3%
Dividend yield 9.29% 8.89% 10.43% 7.33%
Ongoing charges
(year ended 31/12/13) 2.26%
As at 30 September 2014 1 year 3 years 5 years
Value of £100 invested
(dividends reinvested) 106.8 162.3 147.5
FTSE ALL-Share 106.1 147.9 159.1
Total Return; Net Income Reinvested, GBP.
Source: Walker Crips Stockbrokers Limited and Fundamental Data Limited.
Source: Association of Investment Companies and Morningstar.
The Board is not aware of any significant events or transactions which have
occurred between 30 September 2014 and the date of publication of this interim
management statement which would have a material impact on the financial
position of the Company. For latest performance information, please refer to
the Company's website, www.baitgroup.co.uk.
For British & American Investment Trust PLC
29 October 2014
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.